Senores Pharmaceuticals Limited Board Approves Variation in Unutilised IPO Proceeds Utilization
Senores Pharmaceuticals Limited announced that its Board of Directors approved a variation concerning the utilization of unutilised portions of its Initial Public Offer (IPO) proceeds. The decision was made during the Board meeting held on June 29, 2026.The company's Board considered and sanctioned the proposed change to the use of unutilized IPO funds. This modification pertains to a portion amounting to ₹ 1000.16 million out of the total primary IPO proceeds of ₹ 5000.00 million.
The variation in the utilization of these funds is subject to final approval from Shareholders through a Postal Ballot.
Key financial details regarding the IPO proceeds are as follows:
| Metric | Value (₹) |
|---|---|
| Total Primary IPO Proceeds | 5000.00 million |
| Variation in Unutilised Proceeds Approved | 1000.16 million |
SENORES Stock Price Movement
Today, Senores Pharmaceuticals Limited shares edged higher to settle at ₹1319.60 after closing up 3.57%. The stock saw active trading as it climbed throughout the session, with 351,732 shares transacted in the market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.